Please join Pearl Pathways at the upcoming INpact meeting on April 20, 2012. Pearl Pathways COO, Gretchen Bowker, will serve as a panelist at the meeting. The topic of the meeting will be the FDA 510(k) process and how it will affect and change medical devices companies. The meeting will be held from 11:30AM-1:00PM at Bingham Greenebaum Doll LLP in Indianapolis, Indiana. To learn more, click here.
Obstacles Facing Biosimilars
Still in its infancy in the U.S., the industry faces some growing pains.
Life Science Accelerated
Our experts are dedicated to expediting life science product development regulatory pathways.